Global Choroidal Neovascularization Market to grow at a CAGR of 6.64% during the period 2016 - 2020; Finds New Report

Report forecast the global choroidal neovascularization market to grow at a CAGR of 6.64% during the period 2016-2020.

Choroidal neovascularization is the formation of new blood vessels in the choroid layer of the eye. These vessels grow through the Bruch membrane into the subretinal space, blocking the proper functioning of retina and leading to vision loss. The condition is often associated with myopia, malignant myopic degeneration, or age-related macular degeneration (AMD).

The report covers the present scenario and the growth prospects of the global choroidal neovascularization market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment and prevention of choroidal neovascularization.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, Better infrastructure in terms of healthcare facilities and sophisticated treatment options has led to a rise in the life expectancy rates, leading to a rise in the number of people over 60 years. The normal aging process results in reduced choroidal blood flow, which leads to ischemia. This, in turn, leads to increased expression of VEGF and development of excess blood vessels resulting in choroidal neovascularization and finally the loss of vision. With the increase in older population, the demand for choroidal neovascularization drugs is also increasing.

Further, the report states that High cost of treatment restricts the market growth.

Global Choroidal Neovascularization Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the Global Choroidal Neovascularization Market: Bayer HealthCare, Novartis, Regeneron Pharmaceuticals and F. Hoffmann-La Roche.

Other Prominent Vendors in the market are: Alcon, Allergan, Avalanche, Bausch and Lomb, Gilead Sciences, Iconic Therapeutics, Lpath, Neurotech Pharmaceuticals, Ohr Pharmaceutical, Opthea, Ophthotech, PanOptica, Pfizer, Promedior, QLT, Quark, Resolvyx Pharmaceuticals, RXi Pharmaceuticals, Sagent Pharmaceuticals, Santen and Sanwa Kagaku Kenkyusho.

Market driver

• Growing older population
• For a full, detailed list, view our report

Market challenge

• High cost of treatment
• For a full, detailed list, view our report

Market trend

• Strategic alliances and M&A
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 56 pages and 28 Exhibit “Global Choroidal Neovascularization Market 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market Overview, Market Landscape, Disease overview, Product portfolio of approved therapies, Pipeline analysis, Market segmentation by ROA, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://mrr.cm/JkD

Related Reports;

Global Consumer Healthcare Market 2016-2020 - Visit at - http://mrr.cm/JkV

Global Drug-Eluting Stent Market 2016-2020 - Visit at - http://mrr.cm/Jkj